WO2006063593A2 - A system and a method for treating of obesity by use of an intragastric balloon - Google Patents

A system and a method for treating of obesity by use of an intragastric balloon Download PDF

Info

Publication number
WO2006063593A2
WO2006063593A2 PCT/DK2005/000793 DK2005000793W WO2006063593A2 WO 2006063593 A2 WO2006063593 A2 WO 2006063593A2 DK 2005000793 W DK2005000793 W DK 2005000793W WO 2006063593 A2 WO2006063593 A2 WO 2006063593A2
Authority
WO
WIPO (PCT)
Prior art keywords
balloon
electrical circuitry
regulating
transponder
signal
Prior art date
Application number
PCT/DK2005/000793
Other languages
French (fr)
Other versions
WO2006063593A3 (en
Inventor
Rune Wessel Weltlesen
Ole Strange
Original Assignee
Rune Wessel Weltlesen
Ole Strange
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rune Wessel Weltlesen, Ole Strange filed Critical Rune Wessel Weltlesen
Publication of WO2006063593A2 publication Critical patent/WO2006063593A2/en
Publication of WO2006063593A3 publication Critical patent/WO2006063593A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/003Implantable devices or invasive measures inflatable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013Implantable devices or invasive measures
    • A61F5/0036Intragastrical devices
    • A61F5/004Intragastrical devices remotely adjustable

Definitions

  • the present invention relates to an intragastric balloon device adapted to be inflated inside the stomach of a patient for treating obesity by reducing the stomach volume.
  • U.S. Pat. No. 6,733,512 is generally directed to an intragastric balloon device adapted to be inserted into the stomach for treating obesity in humans by reducing the stomach volume.
  • the intragastric balloon device includes a flexible, inflatable balloon having an interior chamber defining a volume.
  • a portion of the balloon has a self-sealing valve thereon to facilitate the introduction of an insufflation catheter into the interior chamber and to facilitate sealing of the catheter track upon removal of the insufflation catheter.
  • the volume of the interior chamber, and the volume occupied by the balloon within the stomach of a patient, is adjusted by injecting an inflation fluid into the balloon's interior chamber.
  • the balloon further includes a deflation valve in a portion thereof.
  • the deflation valve is a patch that has a bioabsorbable or biodegradable portion.
  • the patch forms a portion of the wall of the balloon and is in leakproof engagement therewith.
  • the deflation valve becomes leaky due to disintegration of the bioabsorbable or biodegradable material and the balloon deflates within the stomach, thereafter to be passed through the patient's digestive tract and excreted.
  • the residence time of the balloon within the stomach depends upon the choice of biodegradable material incorporated into the patch and the construction of the deflation valve.
  • 6,676,674 is generally directed to a gastric band of a belt type is presented for attaching around a circumference of a patient's stomach, so as to define the diameter of the stomach opening.
  • the band comprises outer and inner surfaces, wherein the inner surface engages the stomach, and at least the outer surface is formed by an elongated member substantially non-extendable along a longitudinal axis thereof.
  • a through-going opening is made in the elongated member and is located so as to define an end portion of the band having a predetermined length.
  • An opposite end portion of the band is shaped so as to be insertable into the through-going opening for adjusting a desired inner diameter of the band in its closed operating position and fastening the opposite end portion to the outer surface of the band.
  • U.S. Pat. No. 6,600,953 is generally directed to an apparatus for treating a condition such as obesity.
  • the apparatus includes a set of one or more electrodes, which are adapted to be applied to one or more respective sites in a vicinity of a body of a stomach of a patient.
  • a control unit is adapted to drive the electrode set to apply to the body of the stomach a signal, configured such that application thereof increases a level of contraction of muscle tissue of the body of the stomach, and decreases a cross-sectional area of a portion of the body of the stomach for a substantially continuous period greater than about 3 seconds.
  • U.S. Pat. No. 5,234,454 is generally directed to a method for controlling the body weight of a patient employs a percutaneous intragastric balloon catheter (10).
  • the method comprises the first steps of inserting a percutaneous intragastric balloon catheter (10) into the stomach of the patient through a gastrostomy tract.
  • the intragastric balloon catheter (10 comprises elongated shaft means (11) having first (12) and second (13) ends, a first inflatable balloon (14) carried proximal to the first end; a second inflatable balloon (15) carried proximal to the first inflatable balloon, the second balloon having a lesser inflated volume than the first balloon; first and second inflation lumens (18, 20); first and second inflation ports (22, 23) communicating respectively with the first and second inflation lumens and the first and second balloons, which ports are carried by the second end (13); a drainage lumen (16) passing between said first and second ends.
  • the method continues by inflating the first and second balloons within the patient, partially filling the stomach to provide satiety.
  • the intragastric balloon catheter employed is also deemed to be novel.
  • U.S. Pat. No. 4,899,747 is generally directed to a stomach insert for treating obesity in humans by reducing the stomach volume comprises a flexible, free floating and unattached, inflatable balloon, the balloon being inflatable to a volume effective to reduce the stomach volume of a person being treated. At least a portion of the balloon has a self-sealing substance to facilitate puncture thereof with insufflation means through which the balloon is inflated and to facilitate sealing of the puncture upon removal of the insufflation means.
  • the method herein comprises positioning the balloon inside the stomach of the person being treated for obesity so as to reduce the stomach volume.
  • U.S. Pat. No. 4,694,827 is generally directed to a balloon insertable and inflatable in the stomach to deter ingestion of food and having, when inflated, a plurality of smooth-surfaced convex protrusions disposed to permit engagement of the stomach wall by the balloon only at spaced localities, for minimizing mechanical trauma of the stomach wall by the balloon.
  • U.S. Pat. No. 6,615,084 is generally directed to an improved process using electrostimulation for treating obesity, especially morbid obesity, and other syndromes related to motor disorders of the stomach is provided.
  • the improved method of this invention provides electrostimulation on the lesser curvature of the stomach, preferably on the lower or distal end of the lesser curvature, which provides improved control of obesity and other syndromes related to motor disorders of the stomach.
  • the process employs stimulation of the lesser curvature at a rate of about 2 to about 14 pulses/minute with each pulse lasting about 0.5 to about 4 seconds such that there is a pause of about 3 to about 30 between the pulses.
  • the pulse rate is about 12 pulses/minute with each pulse lasting about 2 seconds with a pause of about 3 seconds between pulses.
  • the pulse amplitude is about 0.5 to about 15 milliamps. More preferable, each pulse consists of a train of micro-bursts with a frequency of about 5 to about 100 sec-1.
  • An aim of the present invention is to provide an improved system and an improved method for treating obesity in humans by reducing the stomach volume.
  • an apparatus for reducing the stomach volume comprising: an intragastric transponder being a single unit comprising RF wireless signal receiving means, electrical signal processing means and transformer means for transforming wireless energy from a received RF wireless signal into electric energy to supply said electrical signal processing means, said transponder having first and second signal outputs to thereby provide a voltage difference for inflating or deflating a balloon inside the stomach, said first and second signal outputs being in electrical contact with the electrical signal processing means of the transponder; and an external stimulator comprising a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby said external stimulator controls the volume of the device being the balloon.
  • the apparatus is adapted for an intragastric balloon device adapted to be inflated inside the stomach for treating obesity in humans by reducing the stomach volume.
  • the transponder has no wiring, electrodes or conductors reaching more than 2 mm from the exterior of the housing of the transponder, and it is even more preferred that the transponder has no wiring, electrodes or conductors reaching outside the exterior of the housing of the transponder.
  • the frequency of the RF-signal is in the range of 100-200 kHz or in the range of 125-150 kHz.
  • the transponder has an elongated form with a first and a second end, and wherein the balloon is encapsulated.
  • the intragastric balloon device may include a flexible, inflatable balloon having an interior chamber defining a volume and one or more transponders.
  • an intragastric balloon device adapted to be inflated or deflated inside the stomach of a patient for treating obesity in humans by reducing the stomach volume
  • said apparatus comprising: an intragastric balloon device being a single unit comprising RF wireless signal receiving means, electrical signal processing means and transformer means for transforming wireless energy from a received RF wireless signal into electric energy to supply said electrical signal processing means, said transponder having first and second signal outputs to thereby provide a voltage difference inflating or deflating of balloon, said external stimulator comprising a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby said external stimulator controls the inflating or deflating of the balloon inside the patients stomach.
  • the intragastric device has no wiring, electrodes or conductors reaching outside the exterior of the housing of the device.
  • the frequency of the RF-signal is in the range of 100-200 kHz or in the range of 125- 15O kHz.
  • intragastric device has an elongated form with a first and a second end.
  • the intragastric device makes use of a compressor or pump to regulate the volume of the balloon. It is also preferred that the intragastric device makes use of electrolysis to regulate the volume of the balloon. Alternatively or additional, the intragastric device may use fuel cells to regulate the volume of the balloon. It is preferred that the intragastric device uses a valve to regulate the volume of the balloon.
  • a pressure gauge is added to the intragastric device to measure the pressure in the stomach and/or the balloon.
  • the intragastric device makes use of a chemical process to regulate the volume of the balloon.
  • a medical system for treating of obesity by use of an intragastric balloon adapted to be inflated or deflated inside the stomach of a patient for treating obesity by reducing the stomach volume comprising: an intragastric balloon, and regulating electrical circuitry having one or more signal outputs to thereby provide one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon, said balloon and said regulating electrical circuitry being connected together so as to at least partly form an integral intragastric device.
  • the regulating electrical circuitry is adapted to inductively receive an externally applied electric control signal. It is also preferred that the regulating electrical circuitry is adapted to inductively receive an externally applied electric power signal.
  • the intragastric device comprises a transponder including at least part of or all of the regulating electrical circuitry, said transponder thereby having one or more signal outputs for providing the one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon.
  • the transponder may comprise RF wireless signal receiving means, electrical signal processing means and transformer means for transforming wireless energy from a received RF wireless signal into electric energy to supply said electrical signal processing means, and the signal output(s) may be controlled by the electrical processing means of the transponder.
  • system of the third aspect of the invention further comprises an external stimulator having a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby the external stimulator is adapted to provide one or more inputs to the signal processing means of the transponder to thereby control the signal output(s) of the transponder.
  • an external stimulator having a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby the external stimulator is adapted to provide one or more inputs to the signal processing means of the transponder to thereby control the signal output(s) of the transponder.
  • the regulating electrical circuitry or transponder may be arranged inside the balloon.
  • the regulating electrical circuitry or the transponder may be arranged outside the balloon, when the balloon is inflated.
  • the intragastric device has no wiring, electrodes or conductors reaching outside the exterior of the housing of the device.
  • the externally applied electric signal(s) may be wireless RF-signals.
  • the frequency of the RF-signal(s) may be in the range of 100-200 kHz or in the range of 125-150 kHz.
  • the intragastric device has an elongated form with a first and a second end when the balloon is in a deflated position.
  • the intragastric device may further comprise a pump or a compressor for introducing a fillant to the balloon to thereby inflate the balloon.
  • the pump or compressor may further be adapted for removing the fillant from the balloon to thereby deflate the balloon. It is preferred that the pump or compressor is controlled by a voltage difference provided by a signal output of the regulating electrical circuitry.
  • the signal output may be a first signal output and the voltage difference may be a first voltage difference.
  • the intragastric device further comprises a gas reservoir for at least partly inflating the balloon.
  • the intragastric device may further comprise an actuator for activating said gas reservoir to thereby at least partly inflating the balloon.
  • the actuator is controlled by a voltage difference provided by a signal output of the regulating electrical circuitry, which signal output may be a second signal output and which voltage difference may be a second voltage difference.
  • the intragastric device further comprises a valve for at least partly regulating the inflation and/or deflation of the balloon.
  • the valve is preferably controlled by a voltage difference provided by a signal output of the regulating electrical circuitry.
  • the intragastric device may be adapted for inflating the balloon with a biocompatible fillant of at least one of a liquid, a gas and a gel.
  • the intragastric device is adapted for using electrolysis to provide a gas for at least partly inflating the balloon.
  • the electrolysis is preferably controlled by a voltage difference provided by a signal output of the regulating electrical circuitry.
  • the intragastric device may be adapted for using fuel cells to regulate the inflation and/or deflation of the balloon.
  • the third aspect of the invention also covers an embodiment wherein the intragastric device is adapted for using a chemical process to regulate the inflation and/or deflation of the balloon.
  • the integral intragastric device comprises a power source for supplying operating power to the regulating electrical circuitry.
  • the power source may be at least one of a battery, a rechargeable battery and a capacitor.
  • a method for treating of obesity by use of an intragastric balloon adapted to be inflated or deflated inside the stomach of a patient for treating obesity by reducing the stomach volume comprising: disposing in the stomach of the patient an intragastric device comprising an intragastric balloon and a regulating electrical circuitry having one or more signal outputs to thereby provide one or more voltage differences for at least partly regulating inflating and/or deflating of the balloon; and actuating the regulating electrical circuitry to thereby provide one or more voltage differences to thereby actuate one or more fillant sources for inflating the balloon.
  • the regulating electrical circuitry is adapted to inductively receive an externally applied electric control signal. It is also preferred that the regulating electrical circuitry is adapted to inductively receive an externally applied electric power signal.
  • the intragastric device comprises a transponder including at least part of or all of said regulating electrical circuitry, said transponder thereby having one or more signal outputs for providing the one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon.
  • the transponder may comprise RF wireless signal receiving means, electrical signal processing means and transformer means for transforming wireless energy from a received RF wireless signal into electric energy to supply said electrical signal processing means, and the signal output(s) may be controlled by the electrical signal processing means of the transponder.
  • an external stimulator is provided, said external stimulator having a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby said external stimulator is adapted to provide one or more inputs to the electrical processing means of the transponder to thereby control the signal output(s) of the transponder, and it is preferred that said actuating comprises providing one or more inputs to the electrical signal processing means of the transponder by means of the external stimulator.
  • the method further comprises the step of inflating the balloon to occupy a large portion of the stomach of the patient to provide a feeling of satiety.
  • the intragastric device further comprises a gas reservoir
  • the actuating of one or more fillant sources comprises actuating the regulating electrical circuitry to provide a voltage difference for actuating the gas reservoir to thereby at least partly inflating the balloon.
  • the intragastric device further comprises a pump or a compressor for introducing a fillant to the balloon to thereby inflate the balloon
  • the actuating of one or more fillant sources comprises actuating the regulating electrical circuitry to provide a voltage difference for actuating the pump or compressor to thereby at least partly inflating the balloon.
  • the method of the third aspect of the invention also covers an embodiment, wherein the actuating of one or more fillant sources comprises the use of electrolysis to provide a gas for at least partly inflating the balloon.
  • the gas provided by the electrolysis may be pumped into the balloon by the pump to thereby at least partly inflating the balloon.
  • the present invention also covers one or more embodiments of an apparatus or system of the present invention further being adapted for providing electro stimulation for obesity. It is also within an embodiment of a method of the present invention that the method further comprises electro stimulation for obesity. It is preferred that the pulse rate is about 12 pulses/minute with each pulse lasting about 2 seconds with a pause of about 3 seconds between pulses. Preferably, the pulse amplitude is about 0.5 to about 15 milliamps. More preferable, each pulse consists of a train of micro-bursts with a frequency of about 5 to 100 sec-1.
  • the intragastric device of the present invention may be swallowed by the patient, and the volume of the interior chamber and the volume occupied by the balloon within the stomach of the patient, may be remotely increased by means of a transponder. Afterwards the dimensions of the balloon in the stomach are greater than the oesophageal opening and gastric outlet of the stomach.
  • the intragastric device may further include a deflation valve controlled by a transponder.
  • the volume of the balloon within the stomach of the patient can remotely be increased or decreased by transponders transforming wireless energy from a received RF wireless signal into electric energy.
  • the deflation valve may be activated by a remote-control.
  • the balloon may then deflate within the stomach, thereafter to be passed through the patient's digestive tract and excreted.
  • Fig. 1 illustrates an intragastric balloon device according to an embodiment of the invention in the stomach of a patient before inflation of the balloon
  • Fig. 2 illustrates the intragastric balloon device of Fig. 1 in the stomach of a patient after inflation of the balloon
  • Fig. 3 illustrates the intragastric balloon device of Fig. 2 on its way out of the stomach of a patient after deflation of the balloon
  • Fig. 4 shows an intragastric balloon device according to an embodiment of the invention with an inflated balloon
  • Fig. 5 is a block diagram showing electronic components and other components being part of an intragastric balloon device according to an embodiment of the invention
  • Fig. 6 illustrates an external stimulator or pulse-generator according to an embodiment of the present invention
  • Fig. 7 shows an intragastric balloon device in a deflated position according to an embodiment of the invention
  • Fig. 8 illustrates the use of an external stimulator for communicating with electrical circuitry arranged in the intragastric balloon device according to an embodiment of the invention.
  • Fig. 1 illustrates an intragastric balloon device 101a according to an embodiment of the invention in the stomach of a patient before inflation of the balloon 102.
  • the balloon 102 is flat packed inside the intragastric device prior to inflation.
  • Fig. 2 illustrates the intragastric balloon device 101 b of Fig. 1 in the stomach of a patient after inflation of the balloon.
  • Fig. 3 illustrates the intragastric balloon device 101c of Fig. 2 on its way out of the stomach of a patient after deflation of the balloon.
  • Fig. 4 shows an intragastric balloon device 101 according to an embodiment of the invention with an inflated balloon.
  • the intragastric balloon device or intragastric device 101 may be constructed with an electronic unit 404 comprising such parts as: a pump engine or mechanism 501 , a power unit or power supply 508, and control and communications unit 503.
  • a balloon 402 is mounted to the electronic unit 404.
  • the balloon 402 may be a spherically shaped reservoir made out of very thin PUR.
  • the PUR material is selected because of its strength and ability to sustain the aggressive environment in the stomach. Furthermore this material has a proven track record from use in gastric balloons.
  • the balloon 402 may be high frequency welded to the final shape, welded to the electronic unit 404 and packaged into it to a pill shape, as illustrated in Fig. 7.
  • the manufacturing of the intragastric device 101 may be in a controlled environment, but need not be in a clean room as the device does not have to be sterile when delivered.
  • the balloon 402 may have one or more safety valves 401 to deflate the balloon 402 if desired.
  • the safety valve 401 may be an organic valve, which may be dissolved during time, and such safety valve need not be controlled by the electronic unit 404.
  • the intragastric device 101 may also comprise mechanically safety valves being controlled by the electronic unit 404. Such a valve should be arranged in the vicinity of the electronic unit 404 having control circuitry for controlling the function of such a valve.
  • electrolysis means may be provided, and an electrical current may be applied between a pair of metal electrodes 403 immersed in the gastric fluid.
  • Fig. 5 is a block diagram showing an electronic unit 404 with electronic components and other components being part of an intragastric balloon device 101 according to an embodiment of the invention.
  • a control and communications unit 503 which is adapted for remote wireless communication, and which may include a controller, a memory and programmable logic.
  • the electronic unit 404 further has a power supply 508.
  • the power supply can be one of, or a combination of, a battery, a capacitor, electrolysis, and wireless energy by means of induction (electromagnetic or RF). When the power supply comprises a battery, this may be a rechargeable battery.
  • the electronic unit 404 may also comprise a micro actuator 504 for controlling a gas reservoir 506 and a safety valve 505.
  • the electronic unit 404 may also comprise a pump engine 501 , electrolysis means 502 and communication interface circuitry 507 for communicating with an external stimulation or control circuit 801.
  • the safety valve 505 may be used to deflate the balloon 101. This deflation may either be by the performed on a pre-programmed, predetermined time, or by the remote wireless communication device 503 or if the electronic unit 404 or the intragastric device 101 ceases to work properly.
  • the gas reservoir 506 should contain a gas under pressure. When the correct placement of the intragastric balloon device 506 is asserted by the Physician the micro actuator 504 may be activated by the control unit 503 to release the gas under pressure from the reservoir to inflate the balloon.
  • the gas reservoir 506 should contain enough gas to partly or fully inflate the balloon 402 in the stomach of the patient. This may prevent the balloon 402 from passing through the patient's digestive tract.
  • the gas reservoir 506 may be a MEMS (Micro Electro Mechanical System) device. After this initial inflation boost the pump engine 501 may take over the control of further inflating the balloon 402.
  • the pump engine 501 may be a MEMS (Micro Electro Mechanical System) device, and may be controlled by the control unit 503 to inflate and/or deflate the balloon.
  • the communication interface 507 of the electronic unit 404 may be adapted for communication with an external stimulator 801 by use of wireless communication, such as RF (Radio Frequency), induction, IrDA and/or Bluetooth.
  • wireless communication such as RF (Radio Frequency), induction, IrDA and/or Bluetooth.
  • the safety valve 505 may be a MEMS (Micro Electro Mechanical System) valve device, which can be driven by electrostatic forces.
  • MEMS Micro Electro Mechanical System
  • the power source or supply 508 may be a power source for supplying operating power to the electronic circuitries, and recharging and programming the power source may be performed as needed from an external stimulator or control circuit 801.
  • the power source 508 may be recharged with sufficient energy to allow the integral intragastric device to provide continuous or intermittent operation.
  • electrolysis means 403, 502 In order to provide a gas for the pump engine 501 to inflate the balloon 402, electrolysis means 403, 502 is provided. In order for the electrolysis means 403, 502 to operate, an electrical current should be applied between the pair of metal electrodes 403 immersed in the gastric fluid of the patient. Each electrode attracts ions which are of the opposite charge. Therefore, positively charged ions move towards the cathode, while negatively charged ions move toward the anode. The energy required to separate the ions, and cause them to gather at the respective electrodes, is provided by the electrical power supply 508. At the probes 403, electrons are absorbed or released by the ions, forming a gas that can be used to inflate the balloon. It is preferred that the electronic parts, 503, 504, 507 and 508, are comprised in a single unit being a transponder, which is able to receive and transmit signals by wireless communication to the external control circuit 801.
  • Fig. 6 illustrates an external stimulator 801 or pulse-generator according to an embodiment of the present invention.
  • the external stimulator 801 may comprise a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby the external stimulator 801 may control the volume of the balloon 402.
  • Fig. 7 shows an intragastric balloon device 101a in a deflated position according to an embodiment of the invention.
  • the balloon is flat packed inside the intragastric device, but part of the balloon also covers the outer part of the device 101a.
  • Fig. 8 illustrates the use of an external stimulator 801 for communicating with electrical circuitry arranged in the intragastric balloon device 101b according to an embodiment of the invention.

Abstract

The present invention relates to a system and a method for treating of obesity by use of an intragastric balloon adapted to be inflated or deflated inside the stomach of a patient for treating obesity by reducing the stomach volume. The system comprises an intragastric balloon, and regulating electrical circuitry having one or more signal outputs to thereby provide one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon. The balloon and the regulating electrical circuitry is connected together so as to at least partly form an integral intragastric device. The method comprises disposing in the stomach of the patient an intragastric device comprising an intragastric balloon and a regulating electrical circuitry having one or more signal outputs to thereby provide one or more voltage differences for at least partly regulating inflating and/or deflating of the balloon, and actuating the regulating electrical circuitry to thereby provide one or more voltage differences to thereby actuate one or more fillant sources for inflating the balloon. The regulating electrical circuitry may be adapted to inductively receive an externally applied electric control signal. The regulating electrical circuitry may also be adapted to inductively receive an externally applied electric power signal. It is preferred that the intragastric device comprises a transponder including at least part of said regulating electrical circuitry, said transponder thereby having one or more signal outputs for providing the one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon.

Description

A SYSTEM AND A METHOD FOR TREATHING OF OBESITY BY USE OF AN INTRAGASTRIC BALLOON
FIELD OF THE INVENTION
The present invention relates to an intragastric balloon device adapted to be inflated inside the stomach of a patient for treating obesity by reducing the stomach volume.
BACKGROUND OF THE INVENTION
Biological and human clinical research has shown utility of treating obesity in humans by reducing the stomach volume.
U.S. Pat. No. 6,733,512 is generally directed to an intragastric balloon device adapted to be inserted into the stomach for treating obesity in humans by reducing the stomach volume. The intragastric balloon device includes a flexible, inflatable balloon having an interior chamber defining a volume. A portion of the balloon has a self-sealing valve thereon to facilitate the introduction of an insufflation catheter into the interior chamber and to facilitate sealing of the catheter track upon removal of the insufflation catheter. The volume of the interior chamber, and the volume occupied by the balloon within the stomach of a patient, is adjusted by injecting an inflation fluid into the balloon's interior chamber. The balloon further includes a deflation valve in a portion thereof. The deflation valve is a patch that has a bioabsorbable or biodegradable portion. The patch forms a portion of the wall of the balloon and is in leakproof engagement therewith. After the balloon has resided within the stomach for a predetermined period of time, the deflation valve becomes leaky due to disintegration of the bioabsorbable or biodegradable material and the balloon deflates within the stomach, thereafter to be passed through the patient's digestive tract and excreted. The residence time of the balloon within the stomach depends upon the choice of biodegradable material incorporated into the patch and the construction of the deflation valve. U.S. Pat. No. 6,676,674 is generally directed to a gastric band of a belt type is presented for attaching around a circumference of a patient's stomach, so as to define the diameter of the stomach opening. The band comprises outer and inner surfaces, wherein the inner surface engages the stomach, and at least the outer surface is formed by an elongated member substantially non-extendable along a longitudinal axis thereof. A through-going opening is made in the elongated member and is located so as to define an end portion of the band having a predetermined length. An opposite end portion of the band is shaped so as to be insertable into the through-going opening for adjusting a desired inner diameter of the band in its closed operating position and fastening the opposite end portion to the outer surface of the band.
U.S. Pat. No. 6,600,953 is generally directed to an apparatus for treating a condition such as obesity. The apparatus includes a set of one or more electrodes, which are adapted to be applied to one or more respective sites in a vicinity of a body of a stomach of a patient. A control unit is adapted to drive the electrode set to apply to the body of the stomach a signal, configured such that application thereof increases a level of contraction of muscle tissue of the body of the stomach, and decreases a cross-sectional area of a portion of the body of the stomach for a substantially continuous period greater than about 3 seconds.
U.S. Pat. No. 5,234,454 is generally directed to a method for controlling the body weight of a patient employs a percutaneous intragastric balloon catheter (10). The method comprises the first steps of inserting a percutaneous intragastric balloon catheter (10) into the stomach of the patient through a gastrostomy tract. The intragastric balloon catheter (10), in turn, comprises elongated shaft means (11) having first (12) and second (13) ends, a first inflatable balloon (14) carried proximal to the first end; a second inflatable balloon (15) carried proximal to the first inflatable balloon, the second balloon having a lesser inflated volume than the first balloon; first and second inflation lumens (18, 20); first and second inflation ports (22, 23) communicating respectively with the first and second inflation lumens and the first and second balloons, which ports are carried by the second end (13); a drainage lumen (16) passing between said first and second ends. The method continues by inflating the first and second balloons within the patient, partially filling the stomach to provide satiety. The intragastric balloon catheter employed is also deemed to be novel.
U.S. Pat. No. 4,899,747 is generally directed to a stomach insert for treating obesity in humans by reducing the stomach volume comprises a flexible, free floating and unattached, inflatable balloon, the balloon being inflatable to a volume effective to reduce the stomach volume of a person being treated. At least a portion of the balloon has a self-sealing substance to facilitate puncture thereof with insufflation means through which the balloon is inflated and to facilitate sealing of the puncture upon removal of the insufflation means. The method herein comprises positioning the balloon inside the stomach of the person being treated for obesity so as to reduce the stomach volume.
U.S. Pat. No. 4,694,827 is generally directed to a balloon insertable and inflatable in the stomach to deter ingestion of food and having, when inflated, a plurality of smooth-surfaced convex protrusions disposed to permit engagement of the stomach wall by the balloon only at spaced localities, for minimizing mechanical trauma of the stomach wall by the balloon.
U.S. Pat. No. 6,615,084 is generally directed to an improved process using electrostimulation for treating obesity, especially morbid obesity, and other syndromes related to motor disorders of the stomach is provided. The improved method of this invention provides electrostimulation on the lesser curvature of the stomach, preferably on the lower or distal end of the lesser curvature, which provides improved control of obesity and other syndromes related to motor disorders of the stomach. In one embodiment, the process employs stimulation of the lesser curvature at a rate of about 2 to about 14 pulses/minute with each pulse lasting about 0.5 to about 4 seconds such that there is a pause of about 3 to about 30 between the pulses. Preferably, the pulse rate is about 12 pulses/minute with each pulse lasting about 2 seconds with a pause of about 3 seconds between pulses. Preferably, the pulse amplitude is about 0.5 to about 15 milliamps. More preferable, each pulse consists of a train of micro-bursts with a frequency of about 5 to about 100 sec-1. SUMMARY OF THE INVENTION
An aim of the present invention is to provide an improved system and an improved method for treating obesity in humans by reducing the stomach volume.
Thus, according to a first aspect of the present invention there is provided an apparatus for reducing the stomach volume, said apparatus comprising: an intragastric transponder being a single unit comprising RF wireless signal receiving means, electrical signal processing means and transformer means for transforming wireless energy from a received RF wireless signal into electric energy to supply said electrical signal processing means, said transponder having first and second signal outputs to thereby provide a voltage difference for inflating or deflating a balloon inside the stomach, said first and second signal outputs being in electrical contact with the electrical signal processing means of the transponder; and an external stimulator comprising a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby said external stimulator controls the volume of the device being the balloon.
In a preferred embodiment of the first aspect of the invention the apparatus is adapted for an intragastric balloon device adapted to be inflated inside the stomach for treating obesity in humans by reducing the stomach volume.
It is preferred that the transponder has no wiring, electrodes or conductors reaching more than 2 mm from the exterior of the housing of the transponder, and it is even more preferred that the transponder has no wiring, electrodes or conductors reaching outside the exterior of the housing of the transponder.
It is preferred that the frequency of the RF-signal is in the range of 100-200 kHz or in the range of 125-150 kHz.
In a preferred embodiment, the transponder has an elongated form with a first and a second end, and wherein the balloon is encapsulated. The intragastric balloon device may include a flexible, inflatable balloon having an interior chamber defining a volume and one or more transponders.
According to a second aspect of the invention there is provided a method and an apparatus for wireless treating of obesity by use of an intragastric balloon device adapted to be inflated or deflated inside the stomach of a patient for treating obesity in humans by reducing the stomach volume, said apparatus comprising: an intragastric balloon device being a single unit comprising RF wireless signal receiving means, electrical signal processing means and transformer means for transforming wireless energy from a received RF wireless signal into electric energy to supply said electrical signal processing means, said transponder having first and second signal outputs to thereby provide a voltage difference inflating or deflating of balloon, said external stimulator comprising a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby said external stimulator controls the inflating or deflating of the balloon inside the patients stomach.
For the apparatus of the second aspect of the invention it is preferred that the intragastric device has no wiring, electrodes or conductors reaching outside the exterior of the housing of the device.
For the apparatus of the second aspect of the invention it is preferred that the frequency of the RF-signal is in the range of 100-200 kHz or in the range of 125- 15O kHz.
For the apparatus of the second aspect of the invention it is preferred that intragastric device has an elongated form with a first and a second end.
According to an embodiment of the invention it is preferred that the intragastric device makes use of a compressor or pump to regulate the volume of the balloon. It is also preferred that the intragastric device makes use of electrolysis to regulate the volume of the balloon. Alternatively or additional, the intragastric device may use fuel cells to regulate the volume of the balloon. It is preferred that the intragastric device uses a valve to regulate the volume of the balloon.
It is within a preferred embodiment that a pressure gauge is added to the intragastric device to measure the pressure in the stomach and/or the balloon.
It is also within an embodiment of the invention that the intragastric device makes use of a chemical process to regulate the volume of the balloon.
According to a third aspect of the invention there is provided a medical system for treating of obesity by use of an intragastric balloon adapted to be inflated or deflated inside the stomach of a patient for treating obesity by reducing the stomach volume, said system comprising: an intragastric balloon, and regulating electrical circuitry having one or more signal outputs to thereby provide one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon, said balloon and said regulating electrical circuitry being connected together so as to at least partly form an integral intragastric device.
For the third aspect of the invention it is preferred that the regulating electrical circuitry is adapted to inductively receive an externally applied electric control signal. It is also preferred that the regulating electrical circuitry is adapted to inductively receive an externally applied electric power signal.
For the third aspect of the invention it is preferred that the intragastric device comprises a transponder including at least part of or all of the regulating electrical circuitry, said transponder thereby having one or more signal outputs for providing the one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon. Here, the transponder may comprise RF wireless signal receiving means, electrical signal processing means and transformer means for transforming wireless energy from a received RF wireless signal into electric energy to supply said electrical signal processing means, and the signal output(s) may be controlled by the electrical processing means of the transponder. It is preferred that the system of the third aspect of the invention further comprises an external stimulator having a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby the external stimulator is adapted to provide one or more inputs to the signal processing means of the transponder to thereby control the signal output(s) of the transponder.
For the system of the third aspect of the invention, the regulating electrical circuitry or transponder may be arranged inside the balloon. Alternatively, the regulating electrical circuitry or the transponder may be arranged outside the balloon, when the balloon is inflated. Also for the system of the third aspect of the invention it is preferred that the intragastric device has no wiring, electrodes or conductors reaching outside the exterior of the housing of the device.
According to an embodiment of the third aspect of the invention, the externally applied electric signal(s) may be wireless RF-signals. Here, the frequency of the RF-signal(s) may be in the range of 100-200 kHz or in the range of 125-150 kHz.
Also for the third aspect of the invention it is preferred that the intragastric device has an elongated form with a first and a second end when the balloon is in a deflated position.
According to an embodiment of the system of the third aspect of the invention, the intragastric device may further comprise a pump or a compressor for introducing a fillant to the balloon to thereby inflate the balloon. Here, the pump or compressor may further be adapted for removing the fillant from the balloon to thereby deflate the balloon. It is preferred that the pump or compressor is controlled by a voltage difference provided by a signal output of the regulating electrical circuitry. Here, the signal output may be a first signal output and the voltage difference may be a first voltage difference.
It is also within an embodiment of the third aspect of the invention that the intragastric device further comprises a gas reservoir for at least partly inflating the balloon. Here, the intragastric device may further comprise an actuator for activating said gas reservoir to thereby at least partly inflating the balloon. It is preferred that the actuator is controlled by a voltage difference provided by a signal output of the regulating electrical circuitry, which signal output may be a second signal output and which voltage difference may be a second voltage difference.
It is also within an embodiment of the third aspect of the invention that the intragastric device further comprises a valve for at least partly regulating the inflation and/or deflation of the balloon. Here, the valve is preferably controlled by a voltage difference provided by a signal output of the regulating electrical circuitry.
According to an embodiment of the third aspect of the invention, the intragastric device may be adapted for inflating the balloon with a biocompatible fillant of at least one of a liquid, a gas and a gel.
It is also within an embodiment of the third aspect of the invention that the intragastric device is adapted for using electrolysis to provide a gas for at least partly inflating the balloon. Here, the electrolysis is preferably controlled by a voltage difference provided by a signal output of the regulating electrical circuitry.
Alternatively or additionally, the intragastric device may be adapted for using fuel cells to regulate the inflation and/or deflation of the balloon.
The third aspect of the invention also covers an embodiment wherein the intragastric device is adapted for using a chemical process to regulate the inflation and/or deflation of the balloon.
For the third aspect of the invention it is preferred that the integral intragastric device comprises a power source for supplying operating power to the regulating electrical circuitry. Here, the power source may be at least one of a battery, a rechargeable battery and a capacitor.
According to the third aspect of the invention there is also provided a method for treating of obesity by use of an intragastric balloon adapted to be inflated or deflated inside the stomach of a patient for treating obesity by reducing the stomach volume, said method comprising: disposing in the stomach of the patient an intragastric device comprising an intragastric balloon and a regulating electrical circuitry having one or more signal outputs to thereby provide one or more voltage differences for at least partly regulating inflating and/or deflating of the balloon; and actuating the regulating electrical circuitry to thereby provide one or more voltage differences to thereby actuate one or more fillant sources for inflating the balloon.
For the method of the third aspect of the invention it is preferred that the regulating electrical circuitry is adapted to inductively receive an externally applied electric control signal. It is also preferred that the regulating electrical circuitry is adapted to inductively receive an externally applied electric power signal.
For the method of the third aspect of the invention it is preferred that the intragastric device comprises a transponder including at least part of or all of said regulating electrical circuitry, said transponder thereby having one or more signal outputs for providing the one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon. Here, the transponder may comprise RF wireless signal receiving means, electrical signal processing means and transformer means for transforming wireless energy from a received RF wireless signal into electric energy to supply said electrical signal processing means, and the signal output(s) may be controlled by the electrical signal processing means of the transponder. It is furthermore preferred that an external stimulator is provided, said external stimulator having a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby said external stimulator is adapted to provide one or more inputs to the electrical processing means of the transponder to thereby control the signal output(s) of the transponder, and it is preferred that said actuating comprises providing one or more inputs to the electrical signal processing means of the transponder by means of the external stimulator.
For the method of the third aspect of the invention it is preferred that the method further comprises the step of inflating the balloon to occupy a large portion of the stomach of the patient to provide a feeling of satiety. The method of the third aspect of the invention also covers an embodiment, wherein the intragastric device further comprises a gas reservoir, and wherein the actuating of one or more fillant sources comprises actuating the regulating electrical circuitry to provide a voltage difference for actuating the gas reservoir to thereby at least partly inflating the balloon.
It is also within an embodiment of the third aspect of the invention that the intragastric device further comprises a pump or a compressor for introducing a fillant to the balloon to thereby inflate the balloon, and wherein the actuating of one or more fillant sources comprises actuating the regulating electrical circuitry to provide a voltage difference for actuating the pump or compressor to thereby at least partly inflating the balloon.
The method of the third aspect of the invention also covers an embodiment, wherein the actuating of one or more fillant sources comprises the use of electrolysis to provide a gas for at least partly inflating the balloon. Here, the gas provided by the electrolysis may be pumped into the balloon by the pump to thereby at least partly inflating the balloon.
The present invention also covers one or more embodiments of an apparatus or system of the present invention further being adapted for providing electro stimulation for obesity. It is also within an embodiment of a method of the present invention that the method further comprises electro stimulation for obesity. It is preferred that the pulse rate is about 12 pulses/minute with each pulse lasting about 2 seconds with a pause of about 3 seconds between pulses. Preferably, the pulse amplitude is about 0.5 to about 15 milliamps. More preferable, each pulse consists of a train of micro-bursts with a frequency of about 5 to 100 sec-1.
The intragastric device of the present invention may be swallowed by the patient, and the volume of the interior chamber and the volume occupied by the balloon within the stomach of the patient, may be remotely increased by means of a transponder. Afterwards the dimensions of the balloon in the stomach are greater than the oesophageal opening and gastric outlet of the stomach. The intragastric device may further include a deflation valve controlled by a transponder.
The volume of the balloon within the stomach of the patient can remotely be increased or decreased by transponders transforming wireless energy from a received RF wireless signal into electric energy.
After the balloon has resided within the stomach for a predetermined period of time the deflation valve may be activated by a remote-control. The balloon may then deflate within the stomach, thereafter to be passed through the patient's digestive tract and excreted.
The invention is described in more detail in the following with reference to the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 illustrates an intragastric balloon device according to an embodiment of the invention in the stomach of a patient before inflation of the balloon,
Fig. 2 illustrates the intragastric balloon device of Fig. 1 in the stomach of a patient after inflation of the balloon,
Fig. 3 illustrates the intragastric balloon device of Fig. 2 on its way out of the stomach of a patient after deflation of the balloon,
Fig. 4 shows an intragastric balloon device according to an embodiment of the invention with an inflated balloon,
Fig. 5 is a block diagram showing electronic components and other components being part of an intragastric balloon device according to an embodiment of the invention,
Fig. 6 illustrates an external stimulator or pulse-generator according to an embodiment of the present invention, Fig. 7 shows an intragastric balloon device in a deflated position according to an embodiment of the invention, and
Fig. 8 illustrates the use of an external stimulator for communicating with electrical circuitry arranged in the intragastric balloon device according to an embodiment of the invention.
DETAILED DESCRIPTION OF THE INVENTION
Fig. 1 illustrates an intragastric balloon device 101a according to an embodiment of the invention in the stomach of a patient before inflation of the balloon 102. The balloon 102 is flat packed inside the intragastric device prior to inflation.
Fig. 2 illustrates the intragastric balloon device 101 b of Fig. 1 in the stomach of a patient after inflation of the balloon.
Fig. 3 illustrates the intragastric balloon device 101c of Fig. 2 on its way out of the stomach of a patient after deflation of the balloon.
Fig. 4 shows an intragastric balloon device 101 according to an embodiment of the invention with an inflated balloon. According to an embodiment of the invention, the intragastric balloon device or intragastric device 101 may be constructed with an electronic unit 404 comprising such parts as: a pump engine or mechanism 501 , a power unit or power supply 508, and control and communications unit 503. A balloon 402 is mounted to the electronic unit 404.
The balloon 402 may be a spherically shaped reservoir made out of very thin PUR. The PUR material is selected because of its strength and ability to sustain the aggressive environment in the stomach. Furthermore this material has a proven track record from use in gastric balloons.
The balloon 402 may be high frequency welded to the final shape, welded to the electronic unit 404 and packaged into it to a pill shape, as illustrated in Fig. 7. The manufacturing of the intragastric device 101 may be in a controlled environment, but need not be in a clean room as the device does not have to be sterile when delivered.
The balloon 402 may have one or more safety valves 401 to deflate the balloon 402 if desired. The safety valve 401 may be an organic valve, which may be dissolved during time, and such safety valve need not be controlled by the electronic unit 404. However, the intragastric device 101 may also comprise mechanically safety valves being controlled by the electronic unit 404. Such a valve should be arranged in the vicinity of the electronic unit 404 having control circuitry for controlling the function of such a valve.
In order to provide a gas for inflating the balloon 402, electrolysis means may be provided, and an electrical current may be applied between a pair of metal electrodes 403 immersed in the gastric fluid.
Fig. 5 is a block diagram showing an electronic unit 404 with electronic components and other components being part of an intragastric balloon device 101 according to an embodiment of the invention. In Fig. 5 there is a control and communications unit 503, which is adapted for remote wireless communication, and which may include a controller, a memory and programmable logic. The electronic unit 404 further has a power supply 508. The power supply can be one of, or a combination of, a battery, a capacitor, electrolysis, and wireless energy by means of induction (electromagnetic or RF). When the power supply comprises a battery, this may be a rechargeable battery. The electronic unit 404 may also comprise a micro actuator 504 for controlling a gas reservoir 506 and a safety valve 505. The electronic unit 404 may also comprise a pump engine 501 , electrolysis means 502 and communication interface circuitry 507 for communicating with an external stimulation or control circuit 801.
The safety valve 505 may be used to deflate the balloon 101. This deflation may either be by the performed on a pre-programmed, predetermined time, or by the remote wireless communication device 503 or if the electronic unit 404 or the intragastric device 101 ceases to work properly. The gas reservoir 506 should contain a gas under pressure. When the correct placement of the intragastric balloon device 506 is asserted by the Physician the micro actuator 504 may be activated by the control unit 503 to release the gas under pressure from the reservoir to inflate the balloon. The gas reservoir 506 should contain enough gas to partly or fully inflate the balloon 402 in the stomach of the patient. This may prevent the balloon 402 from passing through the patient's digestive tract. The gas reservoir 506 may be a MEMS (Micro Electro Mechanical System) device. After this initial inflation boost the pump engine 501 may take over the control of further inflating the balloon 402. The pump engine 501 may be a MEMS (Micro Electro Mechanical System) device, and may be controlled by the control unit 503 to inflate and/or deflate the balloon.
The communication interface 507 of the electronic unit 404 may be adapted for communication with an external stimulator 801 by use of wireless communication, such as RF (Radio Frequency), induction, IrDA and/or Bluetooth.
The safety valve 505 may be a MEMS (Micro Electro Mechanical System) valve device, which can be driven by electrostatic forces.
The power source or supply 508 may be a power source for supplying operating power to the electronic circuitries, and recharging and programming the power source may be performed as needed from an external stimulator or control circuit 801. The power source 508 may be recharged with sufficient energy to allow the integral intragastric device to provide continuous or intermittent operation.
In order to provide a gas for the pump engine 501 to inflate the balloon 402, electrolysis means 403, 502 is provided. In order for the electrolysis means 403, 502 to operate, an electrical current should be applied between the pair of metal electrodes 403 immersed in the gastric fluid of the patient. Each electrode attracts ions which are of the opposite charge. Therefore, positively charged ions move towards the cathode, while negatively charged ions move toward the anode. The energy required to separate the ions, and cause them to gather at the respective electrodes, is provided by the electrical power supply 508. At the probes 403, electrons are absorbed or released by the ions, forming a gas that can be used to inflate the balloon. It is preferred that the electronic parts, 503, 504, 507 and 508, are comprised in a single unit being a transponder, which is able to receive and transmit signals by wireless communication to the external control circuit 801.
Fig. 6 illustrates an external stimulator 801 or pulse-generator according to an embodiment of the present invention. The external stimulator 801 may comprise a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby the external stimulator 801 may control the volume of the balloon 402.
Fig. 7 shows an intragastric balloon device 101a in a deflated position according to an embodiment of the invention. In Fig.7 the balloon is flat packed inside the intragastric device, but part of the balloon also covers the outer part of the device 101a.
Fig. 8 illustrates the use of an external stimulator 801 for communicating with electrical circuitry arranged in the intragastric balloon device 101b according to an embodiment of the invention.
While the invention has been particularly shown and described with reference to particular embodiments, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention, and it is intended that such changes come within the scope of the following claims.

Claims

1. A medical system for treating of obesity by use of an intragastric balloon adapted to be inflated or deflated inside the stomach of a patient for treating obesity by reducing the stomach volume, said system comprising: an intragastric balloon, and regulating electrical circuitry having one or more signal outputs to thereby provide one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon, said balloon and said regulating electrical circuitry being connected together so as to at least partly form an integral intragastric device.
2. A system according to claim 1 , wherein the regulating electrical circuitry is adapted to inductively receive an externally applied electric control signal.
3. A system according to claim 1 or 2, wherein the regulating electrical circuitry is adapted to inductively receive an externally applied electric power signal.
4. A system according to any one of the claims 1-3, wherein the intragastric device comprises a transponder including at least part of said regulating electrical circuitry, said transponder thereby having one or more signal outputs for providing the one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon.
5. A system according to claim 4, wherein the transponder comprises RF wireless signal receiving means, electrical signal processing means and transformer means for transforming wireless energy from a received RF wireless signal into electric energy to supply said electrical signal processing means, and wherein said signal output(s) is(are) controlled by the electrical processing means of the transponder.
6. A system according to claim 4 or 5, said system further comprising: an external stimulator having a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby said external stimulator is adapted to provide one or more inputs to the signal processing means of the transponder to thereby control the signal output(s) of the transponder.
7. A system according to any one of the claims 1-6, wherein the regulating electrical circuitry or transponder is arranged inside the balloon.
8. A system according to any one of the claims 1-6, wherein the regulating electrical circuitry or the transponder is arranged outside the balloon, when the balloon is inflated.
9. A system according to any one of the claims 1-8, wherein the intragastric device has no wiring, electrodes or conductors reaching outside the exterior of the housing of the device.
10. A system according to any one of the claims 2-9, wherein the externally applied electric signal(s) is/are wireless RF-signals.
11. A system according to claim 10, wherein the frequency of the RF-signal(s) is/are in the range of 100-200 kHz or in the range of 125-150 kHz.
12. A system according to any one of the claims 1-11 , wherein the intragastric device has an elongated form with a first and a second end when the balloon is in a deflated position.
13. A system according to any one of the claims 1-12, wherein the intragastric device further comprises a pump or a compressor for introducing a fillant to the balloon to thereby inflate the balloon.
14. A system according to claim 13, wherein the pump or compressor is further adapted for removing the fillant from the balloon to thereby deflate the balloon.
15. A system according to any one of the claims 1-14, wherein the intragastric device further comprises a gas reservoir for at least partly inflating the balloon.
16. A system a according to 15, wherein the intragastric device further comprises an actuator for activating said gas reservoir to thereby at least partly inflating the balloon.
17. A system according to any one of the claims 13-16, wherein the pump or compressor is controlled by a first voltage difference provided by a first signal output of the regulating electrical circuitry.
18. A system according to claim 16 or 17, wherein the actuator is controlled by a voltage difference provided by a signal output of the regulating electrical circuitry.
19. A system according to claim 18, wherein the actuator is controlled by a second voltage difference provided by a second signal output of the regulating electrical circuitry.
20. A system according to any one of the claims 1-19, wherein the intragastric device comprises a valve for at least partly regulating the inflation and/or deflation of the balloon.
21. A system according to claim 19, wherein the valve is controlled by a voltage difference provided by a signal output of the regulating electrical circuitry.
22. A system according to any one of the claims 1-21 , wherein the intragastric device is adapted for inflating the balloon with a biocompatible fillant of at least one of a liquid, a gas and a gel.
23. A system according to any one of the claims 1-22, wherein the intragastric device is adapted for using electrolysis to provide a gas for at least partly inflating the balloon.
24. A system according to claim 23, wherein the electrolysis is controlled by a voltage difference provided by a signal output of the regulating electrical circuitry.
25. A system according to any one of the claims 1-12, wherein the intragastric device is adapted for using fuel cells to regulate the inflation and/or deflation of the balloon.
26. A system according to any one of the claims 1-12, wherein the intragastric device is adapted for using a chemical process to regulate the inflation and/or deflation of the balloon.
27. A system according to any one of the claims 1-26, wherein the integral intragastric device comprises a power source for supplying operating power to the regulating electrical circuitry.
28. A system according to claim 27, wherein the power source is at least one of a battery, a rechargeable battery and a capacitor.
29. A method for treating of obesity by use of an intragastric balloon adapted to be inflated or deflated inside the stomach of a patient for treating obesity by reducing the stomach volume, said method comprising: disposing in the stomach of the patient an intragastric device comprising an intragastric balloon and a regulating electrical circuitry having one or more signal outputs to thereby provide one or more voltage differences for at least partly regulating inflating and/or deflating of the balloon, and actuating the regulating electrical circuitry to thereby provide one or more voltage differences to thereby actuate one or more fillant sources for inflating the balloon.
30. A method according to claim 29, wherein the regulating electrical circuitry is adapted to inductively receive an externally applied electric control signal.
31. A method according to claim 20 or 30, wherein the regulating electrical circuitry is adapted to inductively receive an externally applied electric power signal.
32. A method according to any one of the claims 29-31 , wherein the intragastric device comprises a transponder including at least part of said regulating electrical circuitry, said transponder thereby having one or more signal outputs for providing the one or more voltage differences for a least partly regulating inflating and/or deflating of the balloon.
33. A method according to claim 32, wherein the transponder comprises RF wireless signal receiving means, electrical signal processing means and transformer means for transforming wireless energy from a received RF wireless signal into electric energy to supply said electrical signal processing means, and wherein said signal output(s) is(are) controlled by the electrical signal processing means of the transponder.
34. A method according to claim 32 or 33, said wherein an external stimulator is provided, said external stimulator having a power source, electrical control means, and RF wireless signal transmitting means being capable of transmitting a RF signal to the RF wireless signal receiving means of the transponder, whereby said external stimulator is adapted to provide one or more inputs to the electrical processing means of the transponder to thereby control the signal output(s) of the transponder, and wherein said actuating comprises providing one or more inputs to the electrical signal processing means of the transponder by means of the external stimulator.
35. A method according to any one of the claims 29-36, said method further comprising the step of inflating the balloon to occupy a large portion of the stomach of the patient to provide a feeling of satiety.
36. A method according to any one of the claims 29-35, wherein the intragastric device further comprises a gas reservoir, and wherein the actuating of one or more fillant sources comprises actuating the regulating electrical circuitry to provide a voltage difference for actuating the gas reservoir to thereby at least partly inflating the balloon.
37. A method according to any one of the claims 29-36, wherein the intragastric device further comprises a pump or a compressor for introducing a fillant to the balloon to thereby inflate the balloon, and wherein the actuating of one or more fillant sources comprises actuating the regulating electrical circuitry to provide a voltage difference for actuating the pump or compressor to thereby at least partly inflating the balloon.
38. A method according to any one of the claims 29-37, wherein the actuating of one or more fillant sources comprises the use of electrolysis to provide a gas for at least partly inflating the balloon.
39. A method according claims 37 and 38, wherein the gas provided by the electrolysis is pumped into the balloon by the pump to thereby at least partly inflating the balloon.
PCT/DK2005/000793 2004-12-14 2005-12-14 A system and a method for treating of obesity by use of an intragastric balloon WO2006063593A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200401932 2004-12-14
DKPA200401932 2004-12-14

Publications (2)

Publication Number Publication Date
WO2006063593A2 true WO2006063593A2 (en) 2006-06-22
WO2006063593A3 WO2006063593A3 (en) 2006-08-31

Family

ID=36588234

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2005/000793 WO2006063593A2 (en) 2004-12-14 2005-12-14 A system and a method for treating of obesity by use of an intragastric balloon

Country Status (1)

Country Link
WO (1) WO2006063593A2 (en)

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008127941A2 (en) 2007-04-13 2008-10-23 Allergan, Inc. Remote deflation of intragastric balloon
WO2009055386A2 (en) * 2007-10-23 2009-04-30 Allergan, Inc. Pressure sensing intragastric balloon
WO2009076093A1 (en) * 2007-12-10 2009-06-18 Wilson-Cook Medical Inc. Dynamic volume displacement weight loss device
WO2009097482A1 (en) * 2008-01-30 2009-08-06 Medical Components, Inc. Gastric inflation band with integrated infusion catheter
FR2927797A1 (en) * 2008-02-26 2009-08-28 Patrick Bey Intra-gastric system for overweight or obesity treating application, has balloon connected to motorized aspiration device implantable in stomach, and circulating filling fluid contained in stomach for introducing or extracting balloon
EP2140903A1 (en) * 2008-06-30 2010-01-06 Tyco Healthcare Group LP Valve assembly including a dissolvable valve member
US7699863B2 (en) 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
EP2240134A1 (en) * 2008-01-29 2010-10-20 Milux Holding SA Methods and instruments for treating obesity and gastroesophageal reflux disease
JP2011087790A (en) * 2009-10-23 2011-05-06 Tohoku Univ Intragastric swelling capsule
US7976554B2 (en) 2006-04-19 2011-07-12 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8001974B2 (en) 2006-04-19 2011-08-23 Vibrynt, Inc. Devices and methods for treatment of obesity
US8070768B2 (en) 2006-04-19 2011-12-06 Vibrynt, Inc. Devices and methods for treatment of obesity
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
US8192455B2 (en) 2003-08-13 2012-06-05 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compressive device for percutaneous treatment of obesity
US8267888B2 (en) 2005-03-01 2012-09-18 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US8342183B2 (en) 2006-04-19 2013-01-01 Vibrynt, Inc. Devices and methods for treatment of obesity
US8382775B1 (en) 2012-01-08 2013-02-26 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
EP2563447A1 (en) * 2010-04-30 2013-03-06 Nanyang Technological University A balloon inflating device and a method for inflating a balloon
US8398668B2 (en) 2006-04-19 2013-03-19 Vibrynt, Inc. Devices and methods for treatment of obesity
US8556925B2 (en) 2007-10-11 2013-10-15 Vibrynt, Inc. Devices and methods for treatment of obesity
US8585733B2 (en) 2006-04-19 2013-11-19 Vibrynt, Inc Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8864840B2 (en) 2010-10-19 2014-10-21 Apollo Endosurgery, Inc. Intragastric implants with collapsible frames
US8870966B2 (en) 2010-10-18 2014-10-28 Apollo Endosurgery, Inc. Intragastric balloon for treating obesity
US8920447B2 (en) 2010-10-19 2014-12-30 Apollo Endosurgery, Inc. Articulated gastric implant clip
US8956380B2 (en) 2010-10-18 2015-02-17 Apollo Endosurgery, Inc. Reactive intragastric implant devices
US9125726B2 (en) 2006-06-09 2015-09-08 Apollo Endosurgery, Inc. Intragastric balloon retrieval mechanisms
US9198790B2 (en) 2010-10-19 2015-12-01 Apollo Endosurgery, Inc. Upper stomach gastric implants
US9398969B2 (en) 2010-10-19 2016-07-26 Apollo Endosurgery, Inc. Upper stomach gastric implants
US9463107B2 (en) 2010-10-18 2016-10-11 Apollo Endosurgery, Inc. Variable size intragastric implant devices
US9498365B2 (en) 2010-10-19 2016-11-22 Apollo Endosurgery, Inc. Intragastric implants with multiple fluid chambers
US9668901B2 (en) 2010-10-18 2017-06-06 Apollo Endosurgery Us, Inc. Intragastric implants with duodenal anchors
CN108420579A (en) * 2018-03-29 2018-08-21 郑仕诚 Weight-reducing sac in a kind of stomach with remote control valve
US10070980B2 (en) 2010-10-19 2018-09-11 Apollo Endosurgery Us, Inc. Anchored non-piercing duodenal sleeve and delivery systems
US10507127B2 (en) 2012-06-07 2019-12-17 Epitomee Medical Ltd. Expandable device
US11129793B2 (en) 2013-12-05 2021-09-28 Epitomee Medical Ltd Retentive devices and systems for in-situ release of pharmaceutical active agents

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9326877B2 (en) 2006-09-29 2016-05-03 Apollo Endosurgery, Inc. Apparatus and method for intragastric balloon with in situ adjustment means
US20110270025A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Remotely powered remotely adjustable gastric band system
US8888732B2 (en) 2011-03-11 2014-11-18 Apollo Endosurgery, Inc. Intraluminal sleeve with active agents
US9314362B2 (en) 2012-01-08 2016-04-19 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908011A (en) * 1986-05-22 1990-03-13 Ballobes Aps Method and device for performing a puncturing work on an inflated balloon-like object implanted in a patient
US6579301B1 (en) * 2000-11-17 2003-06-17 Syntheon, Llc Intragastric balloon device adapted to be repeatedly varied in volume without external assistance
US20030171768A1 (en) * 2002-03-07 2003-09-11 Mcghan Jim J. Self-deflating intragastric balloon

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908011A (en) * 1986-05-22 1990-03-13 Ballobes Aps Method and device for performing a puncturing work on an inflated balloon-like object implanted in a patient
US6579301B1 (en) * 2000-11-17 2003-06-17 Syntheon, Llc Intragastric balloon device adapted to be repeatedly varied in volume without external assistance
US20030171768A1 (en) * 2002-03-07 2003-09-11 Mcghan Jim J. Self-deflating intragastric balloon

Cited By (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192455B2 (en) 2003-08-13 2012-06-05 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compressive device for percutaneous treatment of obesity
US7699863B2 (en) 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US8267888B2 (en) 2005-03-01 2012-09-18 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
US8460321B2 (en) 2006-04-19 2013-06-11 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8360069B2 (en) 2006-04-19 2013-01-29 Vibrynt, Inc. Devices and methods for treatment of obesity
US8356605B2 (en) 2006-04-19 2013-01-22 Vibrynt, Inc. Devices and methods for treatment of obesity
US8585733B2 (en) 2006-04-19 2013-11-19 Vibrynt, Inc Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8353925B2 (en) 2006-04-19 2013-01-15 Vibrynt, Inc. Devices and methods for treatment of obesity
US8070768B2 (en) 2006-04-19 2011-12-06 Vibrynt, Inc. Devices and methods for treatment of obesity
US8342183B2 (en) 2006-04-19 2013-01-01 Vibrynt, Inc. Devices and methods for treatment of obesity
US7976554B2 (en) 2006-04-19 2011-07-12 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8001974B2 (en) 2006-04-19 2011-08-23 Vibrynt, Inc. Devices and methods for treatment of obesity
US8398668B2 (en) 2006-04-19 2013-03-19 Vibrynt, Inc. Devices and methods for treatment of obesity
US9125726B2 (en) 2006-06-09 2015-09-08 Apollo Endosurgery, Inc. Intragastric balloon retrieval mechanisms
WO2008127941A2 (en) 2007-04-13 2008-10-23 Allergan, Inc. Remote deflation of intragastric balloon
WO2008127941A3 (en) * 2007-04-13 2008-12-11 Allergan Inc Remote deflation of intragastric balloon
US8556925B2 (en) 2007-10-11 2013-10-15 Vibrynt, Inc. Devices and methods for treatment of obesity
WO2009055386A2 (en) * 2007-10-23 2009-04-30 Allergan, Inc. Pressure sensing intragastric balloon
US8282666B2 (en) 2007-10-23 2012-10-09 Allergan, Inc. Pressure sensing intragastric balloon
WO2009055386A3 (en) * 2007-10-23 2009-09-03 Allergan, Inc. Pressure sensing intragastric balloon
WO2009076093A1 (en) * 2007-12-10 2009-06-18 Wilson-Cook Medical Inc. Dynamic volume displacement weight loss device
EP2240134A1 (en) * 2008-01-29 2010-10-20 Milux Holding SA Methods and instruments for treating obesity and gastroesophageal reflux disease
US9877859B2 (en) 2008-01-29 2018-01-30 Peter Forsell Methods and instruments for treating obesity and gastroesophageal reflux disease
US10945870B2 (en) 2008-01-29 2021-03-16 Peter Forsell Apparatus for treating obesity
US10857018B2 (en) 2008-01-29 2020-12-08 Peter Forsell Apparatus for treating obesity
EP2240134A4 (en) * 2008-01-29 2011-11-30 Milux Holding Sa Methods and instruments for treating obesity and gastroesophageal reflux disease
US9277920B2 (en) 2008-01-29 2016-03-08 Peter Forsell Apparatus for treating GERD comprising a stimulation device
EP2240138B1 (en) * 2008-01-29 2021-07-21 Implantica Patent Ltd. Apparatus for treating obesity
US10653542B2 (en) 2008-01-29 2020-05-19 Peter Forsell Device, system and method for treating obesity
US9060771B2 (en) 2008-01-29 2015-06-23 Peter Forsell Method and instrument for treating obesity
US11510770B2 (en) 2008-01-29 2022-11-29 Peter Forsell Apparatus for treating reflux disease (GERD) and obesity
US10548752B2 (en) 2008-01-29 2020-02-04 Peter Forsell Apparatus and method for treating obesity
US9687335B2 (en) 2008-01-29 2017-06-27 Milux Holding Sa Method and instruments for treating GERD
US10045869B2 (en) 2008-01-29 2018-08-14 Peter Forsell Apparatus for treating obesity and reflux disease
US11020258B2 (en) 2008-01-29 2021-06-01 Peter Forsell Apparatus for treating GERD
US8425401B2 (en) 2008-01-30 2013-04-23 Medical Components, Inc. Gastric inflation band with integrated infusion catheter
WO2009097482A1 (en) * 2008-01-30 2009-08-06 Medical Components, Inc. Gastric inflation band with integrated infusion catheter
FR2927797A1 (en) * 2008-02-26 2009-08-28 Patrick Bey Intra-gastric system for overweight or obesity treating application, has balloon connected to motorized aspiration device implantable in stomach, and circulating filling fluid contained in stomach for introducing or extracting balloon
EP2724744A1 (en) * 2008-06-30 2014-04-30 Covidien LP Valve assembly including a dissolvable valve member
US8518019B2 (en) 2008-06-30 2013-08-27 Covidien Lp Valve assembly including a dissolvable valve member
EP2140903A1 (en) * 2008-06-30 2010-01-06 Tyco Healthcare Group LP Valve assembly including a dissolvable valve member
US8876801B2 (en) 2008-06-30 2014-11-04 Covidien Lp Apparatus, system and method for a dissolvable valve member
JP2011087790A (en) * 2009-10-23 2011-05-06 Tohoku Univ Intragastric swelling capsule
EP2563447A1 (en) * 2010-04-30 2013-03-06 Nanyang Technological University A balloon inflating device and a method for inflating a balloon
CN102970946A (en) * 2010-04-30 2013-03-13 南洋理工大学 A balloon inflating device and a method for inflating a balloon
CN102970946B (en) * 2010-04-30 2016-02-17 南洋理工大学 Air bag expanding device and air bag expanding method
EP2563447A4 (en) * 2010-04-30 2014-03-19 Univ Nanyang Tech A balloon inflating device and a method for inflating a balloon
US9463107B2 (en) 2010-10-18 2016-10-11 Apollo Endosurgery, Inc. Variable size intragastric implant devices
US8956380B2 (en) 2010-10-18 2015-02-17 Apollo Endosurgery, Inc. Reactive intragastric implant devices
US9668901B2 (en) 2010-10-18 2017-06-06 Apollo Endosurgery Us, Inc. Intragastric implants with duodenal anchors
US8870966B2 (en) 2010-10-18 2014-10-28 Apollo Endosurgery, Inc. Intragastric balloon for treating obesity
US9795498B2 (en) 2010-10-18 2017-10-24 Apollo Endosurgery Us, Inc. Intragastric balloon for treating obesity
US9498365B2 (en) 2010-10-19 2016-11-22 Apollo Endosurgery, Inc. Intragastric implants with multiple fluid chambers
US8920447B2 (en) 2010-10-19 2014-12-30 Apollo Endosurgery, Inc. Articulated gastric implant clip
US9198790B2 (en) 2010-10-19 2015-12-01 Apollo Endosurgery, Inc. Upper stomach gastric implants
US10070980B2 (en) 2010-10-19 2018-09-11 Apollo Endosurgery Us, Inc. Anchored non-piercing duodenal sleeve and delivery systems
US8864840B2 (en) 2010-10-19 2014-10-21 Apollo Endosurgery, Inc. Intragastric implants with collapsible frames
US9801747B2 (en) 2010-10-19 2017-10-31 Apollo Endosurgery Us, Inc. Non-inflatable gastric implants and systems
US9681974B2 (en) 2010-10-19 2017-06-20 Apollo Endosurgery Us, Inc. Intragastric implants with collapsible frames
US9539133B2 (en) 2010-10-19 2017-01-10 Apollo Endosurgery, Inc. Stomach-spanning gastric implants
US9398969B2 (en) 2010-10-19 2016-07-26 Apollo Endosurgery, Inc. Upper stomach gastric implants
US8382775B1 (en) 2012-01-08 2013-02-26 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US10507127B2 (en) 2012-06-07 2019-12-17 Epitomee Medical Ltd. Expandable device
US11712356B2 (en) 2012-06-07 2023-08-01 Epitomee Medical Ltd Expanded device
US11129793B2 (en) 2013-12-05 2021-09-28 Epitomee Medical Ltd Retentive devices and systems for in-situ release of pharmaceutical active agents
CN108420579A (en) * 2018-03-29 2018-08-21 郑仕诚 Weight-reducing sac in a kind of stomach with remote control valve

Also Published As

Publication number Publication date
WO2006063593A3 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
WO2006063593A2 (en) A system and a method for treating of obesity by use of an intragastric balloon
US8226602B2 (en) Intragastric balloon system and therapeutic processes and products
US9445930B2 (en) Methods, devices, and systems for obesity treatment
US7054690B2 (en) Gastrointestinal stimulation device
US10524946B2 (en) Methods, devices, and systems for obesity treatment
ES2565586T3 (en) Intragastric space filler
ES2566148T3 (en) System for the treatment of a patient who has an intestinal disorder
EP3108852B1 (en) System for treating a patient having an intestinal disorder
JP2022087266A (en) System for treating urinary retention of mammal patient
EP2349083A1 (en) Artificial stomach

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase in:

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 05818755

Country of ref document: EP

Kind code of ref document: A2